Ketamine for OUD and Suicidal Ideation in the ED

You may not be if

• To be eligible, individuals must be/have:
• English speaking adults aged 18 and above
• Diagnosed with DSM5 opioid use disorder, moderate or severe, or clinically suspected opioid use disorder
• Endorsing suicidal ideation sufficiently severe to meet criteria for referral to an inpatient psychiatric facility or a crisis stabilization unit
• Any prior history of an opioid overdose
• Medically cleared
• Individuals with any of the following will be excluded:
• Any psychotic disorder or active homicidally
• Inability to perform consent due to impaired mental status
• Current substance intoxication or current (or within the past 1-month) mania, hypomania, mixed-episode, or psychosis
• Systolic blood pressure persistently elevated above 160mmHg, diastolic blood pressure greater than 100 mmHg, or heart rate \>100bmp, in the ED
• Clinical Opioid Withdrawal Scale (COWS) score of 12 or greater
• History of hypersensitivity to ketamine, or experience of emergence reaction
• History of hypersensitivity to ondansetron or concurrently using apomorphine
• History of any illicit or recreational use of ketamine in the past 12 months
• Receipt of ketamine treatment for depression in the past 3 months
• History of DSM5 hallucinogen use disorder, intracranial mass or bleed, porphyria, thyrotoxicosis, seizure disorder other than from alcohol withdrawal, liver cirrhosis, or sleep apnea
• Cardiac or EKG abnormalities based on history, physical examination or the baseline EKG
• History within 6 months of thoracic surgery, lung cancer, head trauma, stroke, or myocardial infarction
• Liver dysfunction with LFTs \>3x upper normal limit
• Current use of medications with known drug-drug interactions with ketamine (i.e., St. John's Wort, theophylline, opioid analgesics other than buprenorphine and methadone for the treatment OUD, Central Nervous System (CNS) depressants other than benzodiazepines or phenobarbital)
• Pregnant
• Patients who are breastfeeding
• ASA class 3 or greater or documented history of difficult airway in HER
• Active exacerbation of COPD or asthma
• Currently participating or anticipated to participate in a concurrent investigational clinical trial
• High risk for adverse emotional or behavioral reaction based on the opinion of the study investigators, including evidence of a personality disorder